Obecbtge autol up to 400 mil
Obecabtagene autoleucel, 10 up to 400 million cd19 car-positive viable t cells, including leukapheresis and dose preparation procedures, per infusion
curl https://api.healthcare.dev/v1/codes/hcpcs/Q2058 \ -H "Authorization: Bearer $HDEV_API_KEY"
{
"data": {
"code": "Q2058",
"parent": null,
"status": "active",
"system": "hcpcs",
"display": "Obecbtge autol up to 400 mil",
"billable": true,
"attributes": {
"betos": "O1D",
"coverage": "C",
"action_code": "N",
"type_of_service": "1",
"pricing_indicator": "51",
"action_effective_date": "2026-01-01"
},
"description": "Obecabtagene autoleucel, 10 up to 400 million cd19 car-positive viable t cells, including leukapheresis and dose preparation procedures, per infusion",
"replaced_by": [],
"effective_end": null,
"effective_start": "2025-07-01",
"care_categories": [
"chemotherapy"
],
"care_category_details": [
{
"slug": "chemotherapy",
"name": "Chemotherapy and cancer medicines",
"confidence": 0.95,
"derivation": "source_stated",
"evidence": [
{
"url": "https://www.cms.gov/medicare/coding-billing/healthcare-common-procedure-system/quarterly-update",
"anchor": "HCPCS Level II range Q2041-Q2058"
}
],
"as_of": "2026-10-01T00:00:00.000Z"
}
]
},
"meta": {
"source": "cms-hcpcs",
"data_version": "2026-10"
}
}CMS attributes
Change history
Q2058 has been in effect since 2025-07-01. This page shows HCPCS Level II release 2026-10.
Add as_of=YYYY-MM-DD to the request to get this code exactly as it was on a past date. The change feed (GET /v1/changes) lists what each release added, changed or retired across the whole dataset; a per-code change list isn't published yet.
Use it
curl https://api.healthcare.dev/v1/codes/hcpcs/Q2058 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up HCPCS Level II code Q2058. Tell me what it covers, whether it is active and since when, and any CMS attributes it has.
Source: CMS, release 2026-10. Public domain (D-series CDT codes excluded). Reference data, not medical or billing advice.